Subject    :    [2017 Feb;41(1)] My Sweetheart Is Broken: Role of Glucose in Diabetic Cardiomyopathy
Writer KDA
Date 2017-03-23 10:30:49 Hit 6,462
Diabetes Metab J. 2017 Feb;41(1):1-9. English. Published online Nov 15, 2016.  https://doi.org/10.4093/dmj.2017.41.1.1 
Copyright © 2017 Korean Diabetes Association
   
My Sweetheart Is Broken: Role of Glucose in Diabetic Cardiomyopathy
Manoja K. Brahma,1 Mark E. Pepin,1,2 and Adam R. Wende1
1Division of Molecular and Cellular Pathology, Department of Pathology, The University of Alabama at Birmingham, Birmingham, AL, USA.
2Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, AL, USA.
Corresponding author: Adam R. Wende. Division of Molecular and Cellular Pathology, Department of Pathology, The University of Alabama at Birmingham, BMR2, Office 506, 901 19th Street South, Birmingham, AL 35294-2180 USA. Email: adamwende@uabmc.edu 
 
Received September 23, 2016; Accepted October 11, 2016.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

 
Abstract

Despite overall reductions in heart disease prevalence, the risk of developing heart failure has remained 2-fold greater among people with diabetes. Growing evidence has supported that fluctuations in glucose level and uptake contribute to cardiovascular disease (CVD) by modifying proteins, DNA, and gene expression. In the case of glucose, clinical studies have shown that increased dietary sugars for healthy individuals or poor glycemic control in diabetic patients further increased CVD risk. Furthermore, even after decades of maintaining tight glycemic control, susceptibility to disease progression can persist following a period of poor glycemic control through a process termed "glycemic memory." In response to chronically elevated glucose levels, a number of studies have identified molecular targets of the glucose-mediated protein posttranslational modification by the addition of an O-linked N-acetylglucosamine to impair contractility, calcium sensitivity, and mitochondrial protein function. Additionally, elevated glucose contributes to dysfunction in coupling glycolysis to glucose oxidation, pentose phosphate pathway, and polyol pathway. Therefore, in the "sweetened" environment associated with hyperglycemia, there are a number of pathways contributing to increased susceptibly to "breaking" the heart of diabetics. In this review we will discuss the unique contribution of glucose to heart disease and recent advances in defining mechanisms of action.

   
Keywords:
Cardiomyopathies; Diabetes; Glucose; Metabolism
 

Articles - Reviews in DMJ
No. Subject Date Hit ↓
197 [2017 Jun;41(3)] Satisfaction Survey on Information Technology-Based... 2017-07-06 6,714
196 [2017 Jun;41(3)] The Effect of 12 Weeks Aerobic, Resistance, and Com... 2017-07-06 6,689
195 [2017 Jun;41(3)] Impact of Gender on the Association between Low Ser... 2017-07-06 6,573
194 [2017 Jun;41(3)] Physician-Directed Diabetes Education without a Med... 2017-07-06 6,241
193 [2017 Jun;41(3)] Knowledge, Attitude, and Practice of Iranian Intern... 2017-07-06 6,362
192 [2017 Jun;41(3)] Comparison of Antidiabetic Regimens in Patients wit... 2017-07-06 6,453
191 [2017 Jun;41(3)] Diabetes Prevention in Australia: 10 Years Results ... 2017-07-06 6,346
190 [2017 Jun;41(3)] Comprehensive Approach for Managing the Older Perso... 2017-07-06 6,025
189 [2017 Apr;41(2)] A Cutoff for Age at Menarche Predicting Metabolic S... 2017-07-06 5,973
188 [2017 Apr;41(2)] Addition of Ipragliflozin to Metformin Treatment in... 2017-07-06 6,322

목록

Gets the previous 5 pages.   Go to previous page.  [1]   2   3   4   5     Go to next page. Gets the next  5 pages.